People lost up to 85 pounds on Lilly's experimental weight loss drug, company says

Chronological Source Flow
Back

AI Fusion Summary

Retatrutide, Lilly’s injection, met primary and key secondary endpoints in a phase‑3 trial, yielding up to 30% weight loss—about 85 pounds—comparable to bariatric surgery. The drug has not yet filed for FDA approval but expects to do so this year.
Community Comments
Loading updates...
0